Premium
Neuropace Inc (NPCE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Mr. Joel D. BeckerCEO, President & Director | -1,13k | 19,21k | Sale to Issuer | 17,06 | 141,69k | -0,79% |
| 2026-05-27 | Dr. Martha J. MorrellChief Medical Officer | -358,00 | 6,11k | Sale to Issuer | 17,06 | 52,39k | -0,68% |
| 2026-03-24 | Dr. Martha J. MorrellChief Medical Officer | -1,34k | 17,80k | Sale to Issuer | 13,27 | 47,28k | -2,76% |
| 2025-12-15 | Dr. Martha J. MorrellChief Medical Officer | -25,00k | 399,25k | Automatic Disposition | 15,97 | 48,62k | -33,96% |
| 2026-03-03 | Dr. Martha J. MorrellChief Medical Officer | -1,34k | 18,53k | Sale to Issuer | 13,83 | 48,62k | -2,68% |
| 2026-03-03 | Mr. Joel D. BeckerCEO, President & Director | -5,02k | 69,47k | Sale to Issuer | 13,83 | 96,94k | -4,93% |
| 2026-02-27 | Mr. Joel D. BeckerCEO, President & Director | -1,13k | 16,42k | Sale to Issuer | 14,58 | 17,23k | -6,14% |
| 2026-02-27 | Dr. Martha J. MorrellChief Medical Officer | -358,00 | 5,22k | Sale to Issuer | 14,58 | 74,96k | -0,48% |
| 2026-02-20 | Dr. Martha J. MorrellChief Medical Officer | -3,41k | 48,93k | Sale to Issuer | 14,34 | 75,32k | -4,33% |
| 2025-12-03 | Dr. Martha J. MorrellChief Medical Officer | -1,34k | 22,29k | Sale to Issuer | 16,66 | 78,73k | -1,67% |
| 2025-11-27 | Dr. Martha J. MorrellChief Medical Officer | -357,00 | 5,89k | Sale to Issuer | 16,50 | 80,07k | -0,44% |
| 2025-11-27 | Mr. Joel D. BeckerCEO, President & Director | -1,13k | 18,58k | Sale to Issuer | 16,50 | 15,07k | -6,95% |
| 2025-11-20 | Dr. Martha J. MorrellChief Medical Officer | -3,05k | 41,19k | Sale to Issuer | 13,50 | 80,43k | -3,65% |
| 2025-09-03 | Dr. Martha J. MorrellChief Medical Officer | -1,34k | 12,51k | Sale to Issuer | 9,36 | 83,48k | -1,58% |
| 2025-08-27 | Dr. Martha J. MorrellChief Medical Officer | -357,00 | 3,17k | Sale to Issuer | 8,88 | 84,82k | -0,42% |
| 2025-08-27 | Mr. Joel D. BeckerCEO, President & Director | -1,13k | 10,00k | Sale to Issuer | 8,88 | 12,92k | -8,02% |
| 2025-08-20 | Dr. Martha J. MorrellChief Medical Officer | -3,05k | 26,43k | Sale to Issuer | 8,66 | 85,17k | -3,46% |
| 2025-06-03 | Ms. Rebecca L. KuhnAdvisor | -1,34k | 18,10k | Sale to Issuer | 13,54 | 80,06k | -1,64% |
| 2025-06-03 | Dr. Martha J. MorrellChief Medical Officer | -1,34k | 18,12k | Sale to Issuer | 13,54 | 85,94k | -1,53% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
